Company Filing History:
Years Active: 1993
Title: Yasuo Totsuka: Innovator in Hypoglycemic Agents
Introduction
Yasuo Totsuka is a notable inventor based in Kawasaki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of methods to reduce blood sugar levels. His innovative work has the potential to impact the lives of many individuals suffering from diabetes.
Latest Patents
Totsuka holds a patent for a method of reducing blood sugar levels using a hypoglycemic agent. The patent details pharmaceutical compositions containing the polypeptides BUF-3, BUF-4, and BUF-5, which exhibit hypoglycemic activity. BUF-3 is identified as a homodimer of monomer A, which has a molecular weight of 16 ± 1 kd. BUF-4 is described as a heterodimer of monomer A and monomer B. These products can be produced through cell culture of malignant leukemia cells or by employing recombinant DNA engineering techniques.
Career Highlights
Yasuo Totsuka is associated with Ajinomoto Co., Ltd., a leading company in the food and biotechnology sectors. His work at Ajinomoto has allowed him to focus on innovative solutions in the pharmaceutical industry. Totsuka's dedication to research and development has led to advancements in treatments for diabetes.
Collaborations
Totsuka has collaborated with notable colleagues, including Itaru Kojima and Etsuro Ogata. Their combined expertise has contributed to the successful development of Totsuka's patented hypoglycemic agents.
Conclusion
Yasuo Totsuka is a prominent inventor whose work in hypoglycemic agents showcases his commitment to improving health outcomes. His innovative methods and collaborations highlight the importance of research in the pharmaceutical industry.